ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 597,28
-0,46%
Dow Jones
40 211,72
0,53%
DAX
18 519,86
-0,43%
Brent Oil
83,655
-0,81%
Bitcoin
62 957,84
-2,92%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/04/202114h00Business WireTeva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets & Assessment of Schizophrenia Clinical Outcomes at Upcom...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/04/202117h09Business WireTeva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/202122h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:TEVATeva Pharmaceutical Industries Ltd
20/04/202101h55Dow Jones NewsDrugmakers Accused of Causing Opioid Addiction in Trial -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/202123h42Dow Jones NewsDrugmakers Accused of Causing Opioid Addiction in TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/202114h00Business WireNew Clinical & Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection & Reduction of Migraine Burden Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/202117h29Dow Jones NewsDrugmakers Go on Trial Over Opioid EpidemicNYSE:TEVATeva Pharmaceutical Industries Ltd
15/04/202114h00Business WireTeva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection & AUSTEDO® (deutetrabenazine) Tablets at Upcoming 2021...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202113h30Business WireTeva Canada annonce le lancement du nouvel auto-injecteur AJOVYMD pour le traitement préventif de la migraine chez les adultesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h49TipRanksTeva’s Seffalair And BroPair Spiromax Receive Approval In EUNYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h15Business WireTeva reçoit l'autorisation de mise sur le marché de l'UE pour Seffalair® Spiromax® et BroPair® Spiromax® (xinafoate de ...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h09Business WireTeva erhält EU-Marktzulassung für Seffalair® Spiromax® und BroPair® Spiromax® (Salmeterol Xinafoate / Fluticasone Propi...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202109h00Business WireTeva receives EU Marketing Authorisation for Seffalair® Spiromax® & BroPair® Spiromax® (salmeterol xinafoate / fluticason...NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202115h42Business WireTeva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202113h30Business WireTeva Canada amplifie son engagement envers les aidants canadiens et présente de nouvelles ressources pour soutenir et améli...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/202113h30InvestorsHub NewsWireAPYP New Apnea AI Solution Could Disrupt $3.7B Sleeping Disorder MarketNYSE:TEVATeva Pharmaceutical Industries Ltd
17/03/202121h03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
08/03/202120h46Business WireTeva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressur...NYSE:TEVATeva Pharmaceutical Industries Ltd
04/03/202112h19Dow Jones NewsEuropean Commission Opens Antitrust Investigation Against Teva Over Multiple-Sclerosis DrugNYSE:TEVATeva Pharmaceutical Industries Ltd
01/03/202122h00Business WireTeva to Present at the J.P. Morgan 2021 Global High Yield and Leveraged Finance ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
26/02/202114h00Business WireNew Study Published in Cephalalgia Identifies Mechanistic Differences Among CGRP Migraine TreatmentsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/202122h12Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:TEVATeva Pharmaceutical Industries Ltd
16/02/202121h59Edgar (US Regulatory)Schedule 13gNYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202122h07Edgar (US Regulatory)Annual Report (10-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/202113h00Business WireTeva Reports Fourth Quarter and Full Year 2020 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
14/01/202123h17Business WireTeva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/202121h07Dow Jones NewsCorrection to Drugmakers Raise Prices Article of Jan. 1NYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/202121h01Business WireTeva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results & 2021 Financial Guidance at 8 a.m. ET on Febru...NYSE:TEVATeva Pharmaceutical Industries Ltd
07/01/202122h00Business WireTeva to Present at the 39th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NASDAQ
ADMP
Adamis Pharmaceuticals
USOTC
CPCAY
Cathay Pacific Airways (PK)
NASDAQ
ANSC
Agriculture and Natural ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés